Our researchers are at the forefront of applications based on CRISPR, bacterial enzymes that have been adapted to promote human health. We are finding new DNA-editing enzymes with a broader, more precise reach, as well as RNA- and base-editing tools that target disease without heritable genomic changes. We are also developing a diagnostic tool called SHERLOCK that detects trace levels of infectious agents like Zika.